← Eichor
Study identifier: NCT04834518 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Screening for Islet Autoantibodies in the Israeli Paediatric General Population for Detection of Pre-symptomatic Type-1 Diabetes Mellitus

Condition: Type1diabetes  ·  Sponsor: Rabin Medical Center

PhaseN/A
Planned participants50000
Who can joinAll sexes, 9 Months to 5 Years
Healthy volunteersNo

About this study

A national screening program for children aged 9 months-5 years that will be tested for the presence of islet autoantibodies.Up to 50,000 Children will be screened by their primary care physician all over Israel. The initial screening will be done at the age of 1 year (in conjunction with the routinely collection of blood for CBC ) and repeated at ages 2-5 years. Antibodies will be measured in capillary blood samples using the Ultrasensitive Antibody Detection by Agglutination-PCR (ADAP) technology developed by Enable Biosciences, which is 1,000-10,000 times more analytically sensitive than currently used methods. By using this innovative technology in such a large cohort, the study is anticipated to detect antibodies at an unprecedented earlier age.When positive in the screening, multiple antibodies will be confirmed by a second sample analyzed by the ADAP technology. In addition, multiple antibodies will be also measured using a radio-binding assay (RBA) of a venous blood sample for investigational purpose only. Children with confirmed multiple antibodies (stage 1 or 2 T1D) will be followed up routinely for the appearance of clinical signs of diabetes (HbA1c, repeated OGTT, monitoring of urine and blood glucose where indicated) and will be invited along with their families to attend an educational program. This program will include diabetes education emphasizing on DKA prevention as well as stress assessment for the families involved and stress alleviating interventions. Th…

This description comes directly from the study's public registry record.

Talk to the study team

Moshe Phillip, Prof  ·  972-544-795-995  ·  moshe.phillip@phillipmd.com

Alona Hamou, MSc  ·  972-545-950-277  ·  alonah@clalit.org.il

Always discuss trial participation with your own doctor first.

Locations (7)

Soroka Medical CenterBeersheba, IsraelRecruiting
Rambam Medical CenterHaifa, IsraelNot Yet Recruiting
Hadassah medical CenterJerusalem, IsraelNot Yet Recruiting
Child Health Centers all over Israel (clalit Health Services)Petah Tikva, IsraelRecruiting
Schneider Children Medical Center of IsraelPetah Tikva, IsraelRecruiting
Sheba Medical CenterRamat Gan, IsraelNot Yet Recruiting
Dana-Duek children's hospitalTel Aviv, IsraelNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04834518